Study details
Enrolling now
Nicotinic Receptor Genetic Variation and Alcohol Reward
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NCT IDNCT03294460ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
128
Study length
about 6.6 years
Ages
21–60
Locations
1 site in MD
About this study
Researchers are testing how different people react to alcohol, especially those with a nicotine receptor gene that may increase their risk of alcohol use disorder. The trial will involve healthy adults who are smokers or non-smokers, and it will investigate how variations in this gene affect brain responses to alcohol cues.
Based on ClinicalTrials.gov records.
What participants do
- 1.Receive Alcohol (IV)
- 2.Take Alcohol (Ethanol)
- 3.Take Alcohol (Oral)
PhasePhase 1
DrugAlcohol (Ethanol)
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low12%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
ethanol, DERMATOLOGICALS
Drug routes
infusion, oral